Published in J Clin Invest on February 01, 1998
Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo. J Exp Med (2012) 3.63
Protein disulfide isomerase acts as an injury response signal that enhances fibrin generation via tissue factor activation. J Clin Invest (2008) 2.39
Thrombus formation in vivo. J Clin Invest (2005) 2.38
Role of tissue factor and protease-activated receptors in a mouse model of endotoxemia. Blood (2003) 2.20
Novel mouse hemostasis model for real-time determination of bleeding time and hemostatic plug composition. J Thromb Haemost (2015) 1.54
Monocyte tissue factor-dependent activation of coagulation in hypercholesterolemic mice and monkeys is inhibited by simvastatin. J Clin Invest (2012) 1.51
FVIIa as used pharmacologically is not TF dependent in hemophilia B mice. Blood (2014) 1.50
Extraembryonic expression of EPCR is essential for embryonic viability. Blood (2005) 1.49
Levels of microparticle tissue factor activity correlate with coagulation activation in endotoxemic mice. J Thromb Haemost (2009) 1.46
Tissue factor deficiency causes cardiac fibrosis and left ventricular dysfunction. Proc Natl Acad Sci U S A (2002) 1.31
The role of tissue factor and factor VIIa in hemostasis. Anesth Analg (2009) 1.31
Tissue factor and PAR1 promote microbiota-induced intestinal vascular remodelling. Nature (2012) 1.29
The protein C pathway in tissue inflammation and injury: pathogenic role and therapeutic implications. Blood (2009) 1.21
Tissue factor and thrombosis: The clot starts here. Thromb Haemost (2010) 1.16
Future innovations in anti-platelet therapies. Br J Pharmacol (2008) 1.13
Contribution of host-derived tissue factor to tumor neovascularization. Arterioscler Thromb Vasc Biol (2008) 1.08
Tissue factor is required for uterine hemostasis and maintenance of the placental labyrinth during gestation. Proc Natl Acad Sci U S A (1999) 1.08
Tissue factor-dependent coagulation contributes to alpha-naphthylisothiocyanate-induced cholestatic liver injury in mice. Am J Physiol Gastrointest Liver Physiol (2009) 1.07
Tissue factor-deficiency and protease activated receptor-1-deficiency reduce inflammation elicited by diet-induced steatohepatitis in mice. Am J Pathol (2009) 1.06
Genetic elimination of the binding motif on fibrinogen for the S. aureus virulence factor ClfA improves host survival in septicemia. Blood (2013) 1.03
Low levels of tissue factor lead to alveolar haemorrhage, potentiating murine acute lung injury and oxidative stress. Thorax (2012) 0.99
Protease-activated receptor 1 and hematopoietic cell tissue factor are required for hepatic steatosis in mice fed a Western diet. Am J Pathol (2011) 0.96
Hepatocyte tissue factor activates the coagulation cascade in mice. Blood (2013) 0.90
The cytoplasmic domain of tissue factor contributes to leukocyte recruitment and death in endotoxemia. Am J Pathol (2004) 0.89
Tissue factor-dependent chemokine production aggravates experimental colitis. Mol Med (2011) 0.89
Efficient male and female germline transmission of a human chromosomal vector in mice. Genome Res (2001) 0.88
Role of tissue factor in thrombosis in antiphospholipid antibody syndrome. Lupus (2010) 0.86
EPCR-dependent PAR2 activation by the blood coagulation initiation complex regulates LPS-triggered interferon responses in mice. Blood (2015) 0.84
Mouse embryogenesis requires the tissue factor extracellular domain but not the cytoplasmic domain. J Clin Invest (2000) 0.84
Fibrin facilitates both innate and T cell-mediated defense against Yersinia pestis. J Immunol (2013) 0.83
Tissue factor contributes to neutrophil CD11b expression in alpha-naphthylisothiocyanate-treated mice. Toxicol Appl Pharmacol (2010) 0.83
Excess of heme induces tissue factor-dependent activation of coagulation in mice. Haematologica (2015) 0.82
Wound healing in hemophilia B mice and low tissue factor mice. Thromb Res (2010) 0.81
An accompanying genetic severe deficiency of tissue factor protects mice with a protein C deficiency from lethal endotoxemia. Blood (2010) 0.81
Use of mouse models to study the role of tissue factor in tumor biology. Semin Thromb Hemost (2008) 0.81
In situ assays demonstrate that interferon-gamma suppresses infection-stimulated hepatic fibrin deposition by promoting fibrinolysis. J Thromb Haemost (2006) 0.80
Antibody-based targeting of alternatively spliced tissue factor: a new approach to impede the primary growth and spread of pancreatic ductal adenocarcinoma. Oncotarget (2016) 0.80
Factor VII deficiency impairs cutaneous wound healing in mice. Mol Med (2010) 0.79
Neutralizing blood-borne polyphosphate in vivo provides safe thromboprotection. Nat Commun (2016) 0.78
Low levels of tissue factor rescue protein C-associated pregnancy failure in mice. J Thromb Haemost (2008) 0.78
Role of tissue factor in Mycobacterium tuberculosis-induced inflammation and disease pathogenesis. PLoS One (2014) 0.77
Coagulation in liver toxicity and disease: role of hepatocyte tissue factor. Thromb Res (2014) 0.77
Sharing tissue factor: a winning strategy in tumorigenesis. Arterioscler Thromb Vasc Biol (2008) 0.77
Hepatocyte tissue factor contributes to the hypercoagulable state in a mouse model of chronic liver injury. J Hepatol (2015) 0.77
Alternatively spliced tissue factor is not sufficient for embryonic development. PLoS One (2014) 0.76
Protective and detrimental effects of neuroectodermal cell-derived tissue factor in mouse models of stroke. JCI Insight (2016) 0.76
The role of decidual cells in uterine hemostasis, menstruation, inflammation, adverse pregnancy outcomes and abnormal uterine bleeding. Hum Reprod Update (2016) 0.76
Upregulation of the coagulation factor VII gene during glucose deprivation is mediated by activating transcription factor 4. PLoS One (2012) 0.76
Pharmacological concentrations of recombinant factor VIIa restore hemostasis independent of tissue factor in antibody-induced hemophilia mice. J Thromb Haemost (2016) 0.75
Comment on "tissue factor-dependent chemokine production aggravates experimental colitis". Mol Med (2011) 0.75
The hemostasis system in murine atherosclerosis. Curr Drug Targets (2008) 0.75
Tissue factor, protease activated receptors and pathologic heart remodelling. Thromb Haemost (2014) 0.75
Thrombin-independent contribution of tissue factor to inflammation and cardiac hypertrophy in a mouse model of sickle cell disease. Blood (2016) 0.75
Inactivation of factor VIIa by antithrombin in vitro, ex vivo and in vivo: role of tissue factor and endothelial cell protein C receptor. PLoS One (2014) 0.75
A combined deficiency of tissue factor and PAR-4 is associated with fatal pulmonary hemorrhage in mice. Thromb Res (2016) 0.75
Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis. Am J Pathol (1989) 5.41
In situ detection of tissue factor in vascular endothelial cells: correlation with the malignant phenotype of human breast disease. Nat Med (1996) 4.86
Uniform vascular-endothelial-cell-specific gene expression in both embryonic and adult transgenic mice. Proc Natl Acad Sci U S A (1997) 4.52
Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci U S A (1989) 3.37
Role of tissue factor in embryonic blood vessel development. Nature (1996) 2.54
Lethal E. coli septic shock is prevented by blocking tissue factor with monoclonal antibody. Circ Shock (1991) 2.49
Tissue factor controls the balance of angiogenic and antiangiogenic properties of tumor cells in mice. J Clin Invest (1994) 2.30
Complete sequence of the human tissue factor gene, a highly regulated cellular receptor that initiates the coagulation protease cascade. Biochemistry (1989) 2.29
The structural biology of expression and function of tissue factor. Thromb Haemost (1991) 2.28
Lipopolysaccharide-mediated transcriptional activation of the human tissue factor gene in THP-1 monocytic cells requires both activator protein 1 and nuclear factor kappa B binding sites. J Exp Med (1991) 2.10
Molecular cloning of the cDNA for tissue factor, the cellular receptor for the initiation of the coagulation protease cascade. Cell (1987) 2.09
Monoclonal antibody analysis of purified and cell-associated tissue factor. Thromb Res (1988) 2.00
Tissue factor promotes melanoma metastasis by a pathway independent of blood coagulation. Proc Natl Acad Sci U S A (1995) 1.98
Increased tissue thromboplastin activity in monocytes of patients with meningococcal infection: related to an unfavourable prognosis. Thromb Haemost (1983) 1.96
Fatal embryonic bleeding events in mice lacking tissue factor, the cell-associated initiator of blood coagulation. Proc Natl Acad Sci U S A (1996) 1.93
Initiation of coagulation by tissue factor. CRC Crit Rev Biochem (1988) 1.73
Regulation of the tissue factor gene. FASEB J (1995) 1.67
Expression cloning of a Na(+)-independent neutral amino acid transporter from rat kidney. Proc Natl Acad Sci U S A (1992) 1.64
Targeted disruption of the murine tissue factor gene results in embryonic lethality. Blood (1996) 1.50
Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees. J Clin Invest (1994) 1.50
Abnormalities of blood coagulation in patients with cancer. Mononuclear cell tissue factor generation. J Lab Clin Med (1981) 1.48
Murine tissue factor gene expression in vivo. Tissue and cell specificity and regulation by lipopolysaccharide. Am J Pathol (1993) 1.45
Transcriptional regulation of tissue factor expression in human endothelial cells. Arterioscler Thromb Vasc Biol (1995) 1.44
Lipopolysaccharide induction of tissue factor gene expression in monocytic cells is mediated by binding of c-Rel/p65 heterodimers to a kappa B-like site. Mol Cell Biol (1994) 1.42
Disparate temporal expression of the prothrombin and thrombin receptor genes during mouse development. Am J Pathol (1994) 1.35
Quantitative polymerase chain reaction analysis reveals marked overexpression of interleukin-1 beta, interleukin-1 and interferon-gamma mRNA in the lymph nodes of lupus-prone mice. Mol Immunol (1995) 1.34
Regulation of the tissue factor promoter in endothelial cells. Binding of NF kappa B-, AP-1-, and Sp1-like transcription factors. J Biol Chem (1995) 1.26
Increased monocyte tissue factor expression in coronary disease. Br Heart J (1995) 1.19
Tissue factor expression during human and mouse development. Am J Pathol (1996) 1.19
Mechanism of the tumor necrosis factor alpha-mediated induction of endothelial tissue factor. J Biol Chem (1995) 1.18
Effect of tissue factor deficiency on mouse and tumor development. Proc Natl Acad Sci U S A (1997) 1.17
What's in a Name? The American Society for Investigative Pathology. Am J Pathol (1993) 1.15
Tissue factor is rapidly induced in arterial smooth muscle after balloon injury. J Clin Invest (1993) 1.12
Macrophages, smooth muscle cells, and tissue factor in unstable angina. Implications for cell-mediated thrombogenicity in acute coronary syndromes. Circulation (1996) 1.08
Structure of the murine tissue factor gene. Chromosome location and conservation of regulatory elements in the promoter. Arterioscler Thromb (1992) 1.06
Expression of the human PDGF-B gene is regulated by both positively and negatively acting cell type-specific regulatory elements located in the first intron. EMBO J (1991) 1.04
Astrocytes are the primary source of tissue factor in the murine central nervous system. A role for astrocytes in cerebral hemostasis. J Clin Invest (1993) 1.04
Effects of tissue factor induced by oxygen free radicals on coronary flow during reperfusion. Nat Med (1996) 0.99
Protease inhibitors block lipopolysaccharide induction of tissue factor gene expression in human monocytic cells by preventing activation of c-Rel/p65 heterodimers. J Biol Chem (1994) 0.94
Tissue factor regulation and gene organization. Oxf Surv Eukaryot Genes (1989) 0.90
Antithrombotic effect of a monoclonal antibody against tissue factor in a rabbit model of platelet-mediated arterial thrombosis. Arterioscler Thromb (1992) 0.86
Activation of factor X by factor VIIa complexed with human-mouse tissue factor chimeras requires human exon 3. Thromb Haemost (1996) 0.83
Monoclonal antibody against tissue factor shortens tissue plasminogen activator lysis time and prevents reocclusion in a rabbit model of carotid artery thrombosis. Circulation (1996) 0.82
Selective inhibition of E-selectin, ICAM-1, and VCAM in endothelial cells. Eur J Immunol (1994) 0.80
Cloning of the rat tissue factor cDNA and promoter: identification of a serum-response region. Thromb Haemost (1996) 0.80
LPS induction of gene expression in human monocytes. Cell Signal (2001) 7.61
In vivo measurement of gene expression, angiogenesis and physiological function in tumors using multiphoton laser scanning microscopy. Nat Med (2001) 5.54
The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling. Nat Med (2001) 5.28
Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure. Nat Med (1999) 4.85
Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration. Nat Genet (2001) 4.66
Toll-like receptor 2-mediated NF-kappa B activation requires a Rac1-dependent pathway. Nat Immunol (2000) 3.96
Escherichia coli hemolysin may damage target cell membranes by generating transmembrane pores. Infect Immun (1986) 3.94
Molecular mechanisms of blood vessel growth. Cardiovasc Res (2001) 3.94
Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB. Diabetes (2001) 3.83
Secretion of haemolysin by Escherichia coli. Curr Top Microbiol Immunol (1986) 3.21
Egr-1, a master switch coordinating upregulation of divergent gene families underlying ischemic stress. Nat Med (2000) 2.79
Lipopolysaccharide induction of the tumor necrosis factor-alpha promoter in human monocytic cells. Regulation by Egr-1, c-Jun, and NF-kappaB transcription factors. J Biol Chem (1997) 2.73
Deficiency or inhibition of Gas6 causes platelet dysfunction and protects mice against thrombosis. Nat Med (2001) 2.66
AT(1) receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor. Circulation (2000) 2.57
Tissue plasminogen activator (tPA) deficiency exacerbates cerebrovascular fibrin deposition and brain injury in a murine stroke model: studies in tPA-deficient mice and wild-type mice on a matched genetic background. Arterioscler Thromb Vasc Biol (1999) 2.56
Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization. Nat Med (1998) 2.54
Role of tissue factor in embryonic blood vessel development. Nature (1996) 2.54
Placental growth factor and its receptor, vascular endothelial growth factor receptor-1: novel targets for stimulation of ischemic tissue revascularization and inhibition of angiogenic and inflammatory disorders. J Thromb Haemost (2003) 2.49
Abrupt rate accelerations or premature beats cause life-threatening arrhythmias in mice with long-QT3 syndrome. Nat Med (2001) 2.46
Duodenal calcium absorption in vitamin D receptor-knockout mice: functional and molecular aspects. Proc Natl Acad Sci U S A (2001) 2.42
Effects of disruption of the plasminogen gene on thrombosis, growth, and health in mice. Circulation (1995) 2.38
Tissue factor controls the balance of angiogenic and antiangiogenic properties of tumor cells in mice. J Clin Invest (1994) 2.30
The structural biology of expression and function of tissue factor. Thromb Haemost (1991) 2.28
VEGF gene therapy: stimulating angiogenesis or angioma-genesis? Nat Med (2000) 2.13
Transcription factor hepatocyte nuclear factor 6 regulates pancreatic endocrine cell differentiation and controls expression of the proendocrine gene ngn3. Mol Cell Biol (2000) 2.11
The carboxy-terminal region of haemolysin 2001 is required for secretion of the toxin from Escherichia coli. Mol Gen Genet (1986) 2.02
Characterisation of HlyC and mechanism of activation and secretion of haemolysin from E. coli 2001. FEBS Lett (1985) 2.01
Role of plasminogen system components in focal cerebral ischemic infarction: a gene targeting and gene transfer study in mice. Circulation (1999) 1.97
The plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin. Implications for antiangiogenic strategies. J Cell Biol (2001) 1.94
A novel role for VEGF in endocardial cushion formation and its potential contribution to congenital heart defects. Development (2001) 1.92
Genetical and functional organisation of the Escherichia coli haemolysin determinant 2001. Mol Gen Genet (1985) 1.92
PR39, a peptide regulator of angiogenesis. Nat Med (2000) 1.90
Regulation of an essential innate immune response by the p50 subunit of NF-kappaB. J Clin Invest (1998) 1.89
Role of cyclic AMP response element-binding protein in cyclic AMP inhibition of NF-kappaB-mediated transcription. J Immunol (1997) 1.82
Plasminogen deficiency differentially affects recruitment of inflammatory cell populations in mice. Blood (1998) 1.81
Functional characterization of a cloned haemolysin determinant from E. coli of human origin, encoding information for the secretion of a 107K polypeptide. Mol Gen Genet (1984) 1.75
Plasma tissue factor may be predictive of venous thromboembolism in pancreatic cancer. J Thromb Haemost (2008) 1.70
Role of cardiac myocyte tissue factor in heart hemostasis. J Thromb Haemost (2007) 1.68
Urokinase-type plasminogen activator is effective in fibrin clearance in the absence of its receptor or tissue-type plasminogen activator. Proc Natl Acad Sci U S A (1996) 1.66
Secretion of a 107 K dalton polypeptide into the medium from a haemolytic E. coli K12 strain. Mol Gen Genet (1984) 1.62
Escherichia coli haemolysin forms voltage-dependent ion channels in lipid membranes. Biochim Biophys Acta (1987) 1.61
A novel C-terminal signal sequence targets Escherichia coli haemolysin directly to the medium. J Cell Sci Suppl (1989) 1.60
Hypoxia-associated induction of early growth response-1 gene expression. J Biol Chem (1999) 1.60
Tissue factor transcription driven by Egr-1 is a critical mechanism of murine pulmonary fibrin deposition in hypoxia. Proc Natl Acad Sci U S A (1998) 1.57
Glycosyl-phosphatidylinositol-anchored or integral membrane forms of CD14 mediate identical cellular responses to endotoxin. Proc Natl Acad Sci U S A (1993) 1.55
Requirement of receptor-bound urokinase-type plasminogen activator for integrin alphavbeta5-directed cell migration. J Biol Chem (1996) 1.55
Inactivation of the gene for anticoagulant protein C causes lethal perinatal consumptive coagulopathy in mice. J Clin Invest (1998) 1.55
Elevated cyclic AMP inhibits NF-kappaB-mediated transcription in human monocytic cells and endothelial cells. J Biol Chem (1996) 1.55
Mice lacking the gene encoding tissue-type plasminogen activator show a selective interference with late-phase long-term potentiation in both Schaffer collateral and mossy fiber pathways. Proc Natl Acad Sci U S A (1996) 1.54
Generation and characterization of urokinase receptor-deficient mice. J Clin Invest (1996) 1.54
Novel mouse hemostasis model for real-time determination of bleeding time and hemostatic plug composition. J Thromb Haemost (2015) 1.54
The C-terminal, 23 kDa peptide of E. coli haemolysin 2001 contains all the information necessary for its secretion by the haemolysin (Hly) export machinery. FEBS Lett (1986) 1.54
Structurally similar oxidized phospholipids differentially regulate endothelial binding of monocytes and neutrophils. Proc Natl Acad Sci U S A (1999) 1.53
Changes in procoagulant and fibrinolytic gene expression during bleomycin-induced lung injury in the mouse. J Clin Invest (1995) 1.52
Mice lacking factor VII develop normally but suffer fatal perinatal bleeding. Nature (1997) 1.50
Inhibition of the tissue factor-thrombin pathway limits infarct size after myocardial ischemia-reperfusion injury by reducing inflammation. Am J Pathol (2000) 1.48
Tissue factor antigen is elevated in patients with microvascular complications of diabetes mellitus. Exp Clin Endocrinol Diabetes (1997) 1.48
Function of the plasminogen/plasmin and matrix metalloproteinase systems after vascular injury in mice with targeted inactivation of fibrinolytic system genes. Arterioscler Thromb Vasc Biol (1998) 1.48
Levels of microparticle tissue factor activity correlate with coagulation activation in endotoxemic mice. J Thromb Haemost (2009) 1.46
Transcriptional regulation of tissue factor expression in human endothelial cells. Arterioscler Thromb Vasc Biol (1995) 1.44
Tissue factor mRNA in THP-1 monocytic cells is regulated at both transcriptional and posttranscriptional levels in response to lipopolysaccharide. Mol Cell Biol (1991) 1.44
A mouse model for Zellweger syndrome. Nat Genet (1997) 1.43
Advanced glycation end product-induced activation of NF-kappaB is suppressed by alpha-lipoic acid in cultured endothelial cells. Diabetes (1997) 1.42
Lipopolysaccharide induction of tissue factor gene expression in monocytic cells is mediated by binding of c-Rel/p65 heterodimers to a kappa B-like site. Mol Cell Biol (1994) 1.42
Detection of M. tuberculosis DNA in sarcoidosis: correlation with T-cell response. Lab Invest (1999) 1.41
The clinical implications of sunitinib-induced hypothyroidism: a prospective evaluation. Br J Cancer (2008) 1.41
Advanced glycation end product (AGE)-mediated induction of tissue factor in cultured endothelial cells is dependent on RAGE. Circulation (1997) 1.38
Plasminogen and plasminogen activators protect against renal injury in crescentic glomerulonephritis. J Exp Med (1997) 1.38
Shear stress induction of the tissue factor gene. J Clin Invest (1997) 1.35
Disruption of the plasminogen gene in mice abolishes wound healing after myocardial infarction. Am J Pathol (2000) 1.33
A set of inducible genes expressed by activated human monocytic and endothelial cells contain kappa B-like sites that specifically bind c-Rel-p65 heterodimers. J Biol Chem (1994) 1.33
Identification with monoclonal antibodies of hemolysin produced by clinical isolates of Escherichia coli. J Clin Microbiol (1987) 1.32
Tissue factor deficiency causes cardiac fibrosis and left ventricular dysfunction. Proc Natl Acad Sci U S A (2002) 1.31
Heterogeneous vascular dependence of tumor cell populations. Am J Pathol (2001) 1.31
Identification of polypeptides required for the export of haemolysin 2001 from E. coli. Mol Gen Genet (1985) 1.31
Role of IKK1 and IKK2 in lipopolysaccharide signaling in human monocytic cells. J Biol Chem (1998) 1.31
Vascular endothelial growth factor (VEGF)-C differentially affects tumor vascular function and leukocyte recruitment: role of VEGF-receptor 2 and host VEGF-A. Cancer Res (2001) 1.30
An examination of differences in serum antibody specificities and hypersensitivity reactions as contributing factors to chronic infection with the intestinal protozoan parasite, Giardia muris, in mice. Aust J Exp Biol Med Sci (1983) 1.30
Microparticle-associated tissue factor activity, venous thromboembolism and mortality in pancreatic, gastric, colorectal and brain cancer patients. J Thromb Haemost (2012) 1.29
Regulation of arterial thrombolysis by plasminogen activator inhibitor-1 in mice. Circulation (1998) 1.29
Influence of plasminogen activator inhibitor type 1 on choroidal neovascularization. FASEB J (2001) 1.29
Platelet-associated tissue factor contributes to the collagen-triggered activation of blood coagulation. Biochem Biophys Res Commun (2001) 1.28
RelB modulation of IkappaBalpha stability as a mechanism of transcription suppression of interleukin-1alpha (IL-1alpha), IL-1beta, and tumor necrosis factor alpha in fibroblasts. Mol Cell Biol (1999) 1.28
Regulation of haemolysin synthesis in E. coli determined by HLY genes of human origin. Mol Gen Genet (1985) 1.27
Transcriptional regulation of the tissue factor gene in human epithelial cells is mediated by Sp1 and EGR-1. J Biol Chem (1996) 1.26
Pre-analytical and analytical variables affecting the measurement of plasma-derived microparticle tissue factor activity. Thromb Res (2011) 1.25
Urokinase-dependent plasminogen activation is required for efficient skeletal muscle regeneration in vivo. Blood (2001) 1.25
Cytoglobin expression is upregulated in all tissues upon hypoxia: an in vitro and in vivo study by quantitative real-time PCR. Biochem Biophys Res Commun (2004) 1.22
Development of targeted angiogenic medicine. J Thromb Haemost (2008) 1.22
Intestinal calcium transporter genes are upregulated by estrogens and the reproductive cycle through vitamin D receptor-independent mechanisms. J Bone Miner Res (2003) 1.22
Role of tissue factor in adhesion of mononuclear phagocytes to and trafficking through endothelium in vitro. Blood (1998) 1.21
Effect of human recombinant interleukin-6 and interleukin-8 on monocyte procoagulant activity. Arterioscler Thromb Vasc Biol (1997) 1.21